Cargando…
The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients
BACKGROUND: Sepsis is a global health problem. Therapeutic agents continue to develop for the management of sepsis. Ascorbic acid and thiamine are currently potential agents intensively studied for their benefits in sepsis. METHODS: This study was a randomized controlled trial (RCT) with a pretest-p...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531617/ https://www.ncbi.nlm.nih.gov/pubmed/36204393 http://dx.doi.org/10.2147/IDR.S378523 |
_version_ | 1784801936970612736 |
---|---|
author | Lubis, Bastian Lelo, Aznan Amelia, Putri Prima, Agus |
author_facet | Lubis, Bastian Lelo, Aznan Amelia, Putri Prima, Agus |
author_sort | Lubis, Bastian |
collection | PubMed |
description | BACKGROUND: Sepsis is a global health problem. Therapeutic agents continue to develop for the management of sepsis. Ascorbic acid and thiamine are currently potential agents intensively studied for their benefits in sepsis. METHODS: This study was a randomized controlled trial (RCT) with a pretest-posttest control group design. Randomization was using a computer. The research was conducted at Haji Adam Malik General Hospital Medan and Grand Medistra Hospital. Blood tests were at the Integrated Laboratory of the Faculty of Medicine, University of North Sumatra. The research was for 14 months. The number of patients in this study was 86 septic patients divided into four groups (NaCl, thiamine, ascorbic acid, and combination). The parameters measured were the enzyme MMP-9 and the enzyme TIMP-1. RESULTS: The number of subjects who met the inclusion criteria was 147 patients. Fifty-three patients passed away during the monitoring period, and eight blood samples were damaged. The final data analyzed consisted of 86 subjects. Of the 86 septic patients obtained Based on initial MMP-9 values, MMP-9 levels increased in the 0.9% NaCl group (25.6%), while MMP-9 levels decreased after intervention in the thiamine, ascorbic acid, and combination groups but a significant decrease in MMP-9 was found in the ascorbic acid group (17.2%; p = 0.04) and the combination group (17.9%; p = 0.026). For TIMP-1 levels, a decreasing trend was only in the ascorbic acid (5.1%) and combination (5.9%) but not significant (p > 0.05). The highest MMP-9/TIMP-1 ratio was in septic patients receiving thiamine with a significant linear correlation (p < 0.05) between levels of MMP-9 and the MMP-9/TIMP-1 ratio with a moderate correlation level and significant negative correlation (p < 0.05) between TIMP-1 and the MMP-9/TIMP-1 with a moderate level of correlation. CONCLUSION: Administration of thiamine alone gives better advantages than ascorbic acid alone and their combination. |
format | Online Article Text |
id | pubmed-9531617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-95316172022-10-05 The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients Lubis, Bastian Lelo, Aznan Amelia, Putri Prima, Agus Infect Drug Resist Original Research BACKGROUND: Sepsis is a global health problem. Therapeutic agents continue to develop for the management of sepsis. Ascorbic acid and thiamine are currently potential agents intensively studied for their benefits in sepsis. METHODS: This study was a randomized controlled trial (RCT) with a pretest-posttest control group design. Randomization was using a computer. The research was conducted at Haji Adam Malik General Hospital Medan and Grand Medistra Hospital. Blood tests were at the Integrated Laboratory of the Faculty of Medicine, University of North Sumatra. The research was for 14 months. The number of patients in this study was 86 septic patients divided into four groups (NaCl, thiamine, ascorbic acid, and combination). The parameters measured were the enzyme MMP-9 and the enzyme TIMP-1. RESULTS: The number of subjects who met the inclusion criteria was 147 patients. Fifty-three patients passed away during the monitoring period, and eight blood samples were damaged. The final data analyzed consisted of 86 subjects. Of the 86 septic patients obtained Based on initial MMP-9 values, MMP-9 levels increased in the 0.9% NaCl group (25.6%), while MMP-9 levels decreased after intervention in the thiamine, ascorbic acid, and combination groups but a significant decrease in MMP-9 was found in the ascorbic acid group (17.2%; p = 0.04) and the combination group (17.9%; p = 0.026). For TIMP-1 levels, a decreasing trend was only in the ascorbic acid (5.1%) and combination (5.9%) but not significant (p > 0.05). The highest MMP-9/TIMP-1 ratio was in septic patients receiving thiamine with a significant linear correlation (p < 0.05) between levels of MMP-9 and the MMP-9/TIMP-1 ratio with a moderate correlation level and significant negative correlation (p < 0.05) between TIMP-1 and the MMP-9/TIMP-1 with a moderate level of correlation. CONCLUSION: Administration of thiamine alone gives better advantages than ascorbic acid alone and their combination. Dove 2022-09-30 /pmc/articles/PMC9531617/ /pubmed/36204393 http://dx.doi.org/10.2147/IDR.S378523 Text en © 2022 Lubis et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Lubis, Bastian Lelo, Aznan Amelia, Putri Prima, Agus The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients |
title | The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients |
title_full | The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients |
title_fullStr | The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients |
title_full_unstemmed | The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients |
title_short | The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients |
title_sort | effect of thiamine, ascorbic acid, and the combination of them on the levels of matrix metalloproteinase-9 (mmp-9) and tissue inhibitor of matrix metalloproteinase-1 (timp-1) in sepsis patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531617/ https://www.ncbi.nlm.nih.gov/pubmed/36204393 http://dx.doi.org/10.2147/IDR.S378523 |
work_keys_str_mv | AT lubisbastian theeffectofthiamineascorbicacidandthecombinationofthemonthelevelsofmatrixmetalloproteinase9mmp9andtissueinhibitorofmatrixmetalloproteinase1timp1insepsispatients AT leloaznan theeffectofthiamineascorbicacidandthecombinationofthemonthelevelsofmatrixmetalloproteinase9mmp9andtissueinhibitorofmatrixmetalloproteinase1timp1insepsispatients AT ameliaputri theeffectofthiamineascorbicacidandthecombinationofthemonthelevelsofmatrixmetalloproteinase9mmp9andtissueinhibitorofmatrixmetalloproteinase1timp1insepsispatients AT primaagus theeffectofthiamineascorbicacidandthecombinationofthemonthelevelsofmatrixmetalloproteinase9mmp9andtissueinhibitorofmatrixmetalloproteinase1timp1insepsispatients AT lubisbastian effectofthiamineascorbicacidandthecombinationofthemonthelevelsofmatrixmetalloproteinase9mmp9andtissueinhibitorofmatrixmetalloproteinase1timp1insepsispatients AT leloaznan effectofthiamineascorbicacidandthecombinationofthemonthelevelsofmatrixmetalloproteinase9mmp9andtissueinhibitorofmatrixmetalloproteinase1timp1insepsispatients AT ameliaputri effectofthiamineascorbicacidandthecombinationofthemonthelevelsofmatrixmetalloproteinase9mmp9andtissueinhibitorofmatrixmetalloproteinase1timp1insepsispatients AT primaagus effectofthiamineascorbicacidandthecombinationofthemonthelevelsofmatrixmetalloproteinase9mmp9andtissueinhibitorofmatrixmetalloproteinase1timp1insepsispatients |